606 related articles for article (PubMed ID: 14678947)
21. Effect of simvastatin on high glucose- and angiotensin II-induced activation of the JAK/STAT pathway in mesangial cells.
Banes-Berceli AK; Shaw S; Ma G; Brands M; Eaton DC; Stern DM; Fulton D; Caldwell RW; Marrero MB
Am J Physiol Renal Physiol; 2006 Jul; 291(1):F116-21. PubMed ID: 16449352
[TBL] [Abstract][Full Text] [Related]
22. EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes.
Andl CD; Mizushima T; Oyama K; Bowser M; Nakagawa H; Rustgi AK
Am J Physiol Gastrointest Liver Physiol; 2004 Dec; 287(6):G1227-37. PubMed ID: 15284024
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II-induced tyrosine phosphorylation of signal transducers and activators of transcription 1 is regulated by Janus-activated kinase 2 and Fyn kinases and mitogen-activated protein kinase phosphatase 1.
Venema RC; Venema VJ; Eaton DC; Marrero MB
J Biol Chem; 1998 Nov; 273(46):30795-800. PubMed ID: 9804857
[TBL] [Abstract][Full Text] [Related]
24. Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia.
Kim HY; Park EJ; Joe EH; Jou I
J Immunol; 2003 Dec; 171(11):6072-9. PubMed ID: 14634121
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II activates JAK2/STAT3 pathway and induces interleukin-6 production in cultured rat brainstem astrocytes.
Kandalam U; Clark MA
Regul Pept; 2010 Jan; 159(1-3):110-6. PubMed ID: 19748527
[TBL] [Abstract][Full Text] [Related]
26. Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction.
Negoro S; Kunisada K; Tone E; Funamoto M; Oh H; Kishimoto T; Yamauchi-Takihara K
Cardiovasc Res; 2000 Sep; 47(4):797-805. PubMed ID: 10974228
[TBL] [Abstract][Full Text] [Related]
27. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.
Halfter H; Postert C; Friedrich M; Ringelstein EB; Stögbauer F
Brain Res Mol Brain Res; 2000 Sep; 80(2):198-206. PubMed ID: 11038252
[TBL] [Abstract][Full Text] [Related]
28. JAK/STAT signaling is associated with cardiac dysfunction during ischemia and reperfusion.
Mascareno E; El-Shafei M; Maulik N; Sato M; Guo Y; Das DK; Siddiqui MA
Circulation; 2001 Jul; 104(3):325-9. PubMed ID: 11457752
[TBL] [Abstract][Full Text] [Related]
29. Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells.
Huang JS; Guh JY; Chen HC; Hung WC; Lai YH; Chuang LY
J Cell Biochem; 2001; 81(1):102-13. PubMed ID: 11180401
[TBL] [Abstract][Full Text] [Related]
30. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
31. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.
Frasor J; Barkai U; Zhong L; Fazleabas AT; Gibori G
Mol Endocrinol; 2001 Nov; 15(11):1941-52. PubMed ID: 11682625
[TBL] [Abstract][Full Text] [Related]
32. Role of the JAK/STAT pathway in rat carotid artery remodeling after vascular injury.
Seki Y; Kai H; Shibata R; Nagata T; Yasukawa H; Yoshimura A; Imaizumi T
Circ Res; 2000 Jul; 87(1):12-8. PubMed ID: 10884366
[TBL] [Abstract][Full Text] [Related]
33. Activation of the signal transducers and activators of transcription signaling pathway by growth hormone (GH) in skin fibroblasts from normal and GH binding protein-positive Laron Syndrome children.
Freeth JS; Silva CM; Whatmore AJ; Clayton PE
Endocrinology; 1998 Jan; 139(1):20-8. PubMed ID: 9421393
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin II stimulates Pax-2 in rat kidney proximal tubular cells: impact on proliferation and apoptosis.
Zhang SL; Guo J; Moini B; Ingelfinger JR
Kidney Int; 2004 Dec; 66(6):2181-92. PubMed ID: 15569307
[TBL] [Abstract][Full Text] [Related]
35. Modulation of Janus kinase 2 by cisplatin in cancer cells.
Song H; Sondak VK; Barber DL; Reid TJ; Lin J
Int J Oncol; 2004 Apr; 24(4):1017-26. PubMed ID: 15010843
[TBL] [Abstract][Full Text] [Related]
36. Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.
Liao J; Kobayashi M; Kanamuru Y; Nakamura S; Makita Y; Funabiki K; Horikoshi S; Tomino Y
J Nephrol; 2003; 16(6):841-9. PubMed ID: 14736011
[TBL] [Abstract][Full Text] [Related]
37. Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation.
Gebert CA; Park SH; Waxman DJ
Mol Endocrinol; 1997 Apr; 11(4):400-14. PubMed ID: 9092792
[TBL] [Abstract][Full Text] [Related]
38. Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation.
Liu J; Kern JA
Am J Respir Cell Mol Biol; 2002 Sep; 27(3):306-13. PubMed ID: 12204892
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II interferes with leukemia inhibitory factor-induced STAT3 activation in cardiac myocytes.
Tone E; Kunisada K; Fujio Y; Matsui H; Negoro S; Oh H; Kishimoto T; Yamauchi-Takihara K
Biochem Biophys Res Commun; 1998 Dec; 253(1):147-50. PubMed ID: 9875235
[TBL] [Abstract][Full Text] [Related]
40. Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction.
Schieffer B; Luchtefeld M; Braun S; Hilfiker A; Hilfiker-Kleiner D; Drexler H
Circ Res; 2000 Dec; 87(12):1195-201. PubMed ID: 11110778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
